Learn more

DADE BEHRING MARBURG GMBH

Overview
  • Total Patents
    566
About

DADE BEHRING MARBURG GMBH has a total of 566 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, EPO (European Patent Office) and Germany. Its main competitors in its focus markets biotechnology, measurement and machines are BEHRING DIAGNOSTICS GMBH, STRATEGIC DIAGNOSTICS INC and MICROGENICS CORP.

Patent filings per year

Chart showing DADE BEHRING MARBURG GMBHs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ullman Edwin F 50
#2 Althaus Harald 33
#3 Kraus Michael 30
#4 Hauser Hans-Peter 30
#5 Knapp Stefan 27
#6 Guertler Lutz G 24
#7 Schelp Carsten 23
#8 Zander Norbert 22
#9 Kraus Michael Dr 21
#10 Eberle Josef 20

Latest patents

Publication Filing date Title
DE102007045099A1 Determining the activity of an analyte in a sample comprises treating an analyte-binder complex with ultrasound before or during activity determination
DE102007031708A1 Determination of von Willebrand factor activity in the absence of ristocetin
DE102007030384A1 Method for identifying a transparent object based on its absorption spectrum
DE102007026153A1 Stable D-Dimer liquid preparation
DE102007017906A1 Method for determining the reaction lag phase in an analyte-dependent reaction
DE102007014083A1 Method for preventing multiple use of disposable items in analyzers
DE102006045550A1 Process for the preparation of agglutinable platelet fragments and their use
DE102006035899A1 New polysaccharide-peptide-conjugate, where the peptide portion contains a sequence having a signal group that is splittable by thrombin at its carbon-terminal end, useful in a procedure for determining the thrombin generation in a sample
US2010248218A1 Conjugates, and use thereof in detection methods
DE102006020385A1 Method and device for determining platelet function under flow conditions
DE102006020386A1 Method for determining platelet function under flow conditions
DE102006019520A1 Method for determining high ristocetin cofactor activities of von Willebrand factor
DE102006008613A1 Stabilized preparations of serine endopeptidases, their preparation and use
DE102005062053A1 Diagnostic method to detect hetero-/homozygote expression of marburg I-variant of factor VII-activating protease (FSAP) expression, comprises determining FSAP activity in sample, using differential activity modulator
DE102005062055A1 Diagnostic method to detect hetero-/homozygote expression of marburg I-variant of factor VII-activating protease (FSAP) expression, comprises determining FSAP activity in sample, using differential activity modulator
DE102005038418A1 Factor Xa-based heparin assay using a heparin-modifying component
DE102005028018A1 Method for the standardization of coagulation tests
DE102005026163A1 Antibodies directed against the Marburg I polymorphism of Factor VII activating protease (FSAP), their production and use
DE102005022047A1 Binding partner of the placental growth factor, in particular antibodies directed against the placental growth factor, their production and use
DE102005003145A1 Stablies, chromogenic liquid reagent and its use in coagulation diagnostic tests